Else Nutrition Shares Rally With Plans for Danone Collaboration
By Robb M. Stewart
Else Nutrition's shares soared Monday after the company unveiled plans for a collaboration with Danone that will initially see its plant-based, soy-free products added to the dairy giant's portfolio.
In morning trading, the shares were 35% higher at C$0.44, narrowing their decline so far this year to 20%.
Else, which has been pushing to get its products on store shelves in North America and elsewhere, said that following due diligence by Danone the companies signed a letter of intent for a staged collaboration. They expect to sign a definitive deal by the end of March.
Initially, Else's products will be manufactured, marketed and commercialized by the European company. The companies plan to negotiate opportunities beyond product commercialization.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
November 13, 2023 10:49 ET (15:49 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom